Publication | Open Access
Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes.
180
Citations
41
References
1994
Year
Receptor ComplexesImmunologyTumor BiologyDifferent SignalsSignal Transduction MechanismsSignaling PathwayCell RegulationReceptor Tyrosine KinaseCellular Regulatory MechanismCell SignalingOncostatin MMolecular PathwayReceptor (Biochemistry)Mechanism Of ActionLeukemia Inhibitory FactorCell BiologyTumor MicroenvironmentMolecular ImmunologySignal TransductionSystems BiologyMedicine
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) both bind to the same receptor with high affinity and thus mediate an overlapping spectrum of biological activities, the signal transduction mechanisms for which are unclear. We show that mitogen-activated protein kinases are involved in both the LIF and OSM signal transduction pathways. However, we found that OSM is a much more potent inducer of both mitogen-activated protein kinase activity and biological response, both of which correlate with the expression of a second OSM receptor that does not bind LIF. In addition, different patterns of tyrosine-phosphorylated proteins were stimulated by OSM and LIF. We therefore suggest that the two receptors for OSM can be coupled to different signal transduction events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1